Tony Di Pietro
Follow
Get notifications in MyBN when activity occurs.
Tony Di Pietro
Tony Di Pietro is a Chartered Accountant with significant corporate accounting experience gained in Australia and the UK. He holds a Graduate Diploma of Applied Corporate Governance from the Governance Institute of Australia and is a member of the Australian Institute of Company Directors. Mr Di Pietro has held senior roles within the biotechnology and medtech industry for over 15 years.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 291st | INOVIQ | 33% | 109% |
| 703rd | Frugl Group | 0% | -20% |
| 766th | Advanced Health Intelligence | -2% | -24% |
| 1615th | Nanollose | -60% | -21% |
| 1865th | Invex Therapeutics | -83% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 157th |  | INOVIQ | $1.6m |
| 172nd | | Frugl Group | $806k |
| 173rd | | Advanced Health Intelligence | $772k |
| 175th |  | Invex Therapeutics | $459k |
| 176th |  | Nanollose | $412k |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Chief Financial Officer, Company Secretary, Sienna Cancer Diagnostics | 03 Aug 2020 |
| NEW ROLE: Executive Director, Sienna Cancer Diagnostics | 03 Aug 2020 |
| NEW ROLE: Joint Company Secretary, Chief Financial Officer, INOVIQ | 03 Aug 2020 |
News Articles
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Joint Company Secretary, Chief Financial Officer | | 2020 - 2022 | 157 |
| Executive Director | | 2020 - 2020 | |
| Chief Financial Officer, Company Secretary | | 2014 - 2020 |
